Cite
HARVARD Citation
Wanezaki, S. et al. (n.d.). Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease. Obesity research & clinical practice. 9 (2), pp. 168-174. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wanezaki, S. et al. (n.d.). Soy β-conglycinin improves obesity-induced metabolic abnormalities in a rat model of nonalcoholic fatty liver disease. Obesity research & clinical practice. 9 (2), pp. 168-174. [Online].